Investing.com - Rezolute reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Rezolute announced earnings per share of $-0.37 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.38 on revenue of $0.00.
Rezolute shares are down 43% from the beginning of the year and are trading at $2.70 , down-from-52-week-high.
Rezolute follows other major Healthcare sector earnings this month
Rezolute's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, compared to forecasts EPS of $1.12 on revenue of $7.22B.
Merck ADR had beat expectations on Friday, September 9, 2022 with third quarter EPS of $0.5392 on revenue of $5.69B, compared to forecast for EPS of $0.5165 on revenue of $5.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar